Mitral valve prolapse and mitral regurgitation are common in patients with polycystic kidney disease type 1
Related Experiment Video
Updated: Jul 31, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
A Lumiaho1, R Ikäheimo, R Miettinen
1Department of Medicine, Kuopio University Hospital, Finland. anne.lumiaho@kuh.fi
Insights
Mitral valve prolapse is common in patients with polycystic kidney disease type 1 (PKD1). Other cardiac issues like mitral regurgitation and left ventricular hypertrophy in PKD1 patients are linked to high blood pressure.
Area of Science:
- Cardiology
- Nephrology
- Genetics
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is associated with cardiac valve abnormalities.
- The prevalence of cardiac issues in patients with a specific genotype of ADPKD (PKD1) remains underreported.
Purpose of the Study:
- To investigate the prevalence of cardiac abnormalities in patients with polycystic kidney disease type 1 (PKD1).
- To compare cardiac findings in PKD1 patients with unaffected family members and healthy controls.
Main Methods:
- M-mode and color Doppler echocardiography were used.
- 109 patients with PKD1, 73 unaffected relatives, and 73 healthy controls were studied.
Main Results:
- Mitral valve prolapse was significantly more common in PKD1 patients (26%) compared to controls (10%).
- Hemodynamically significant mitral regurgitation (13%) and left ventricular hypertrophy (19%) were also more prevalent in PKD1 patients.
- Elevated blood pressure and kidney disease severity correlated with mitral regurgitation and left ventricular hypertrophy in PKD1 patients.
Conclusions:
- Mitral valve prolapse is a characteristic cardiac finding in PKD1 patients.
- Mitral regurgitation and left ventricular hypertrophy in PKD1 are likely secondary to hypertension.
- Cardiac abnormalities did not differ between unaffected relatives and healthy controls.
Abstract:
Patients with autosomal dominant polycystic kidney disease (ADPKD) have an increased occurrence of cardiac valve abnormalities. However, the prevalence of cardiac abnormalities in patients with a uniform genotype of ADPKD has not been previously reported. We performed M-mode and color Doppler echocardiography on 109 patients from 16 families with polycystic kidney disease type 1 (PKD1). Findings were compared with those of 73 unaffected family members and 73 healthy controls. Mitral valve prolapse was found in 26% of patients with PKD1, 14% of unaffected relatives, and 10% of control subjects. The prevalence of hemodynamically significant mitral regurgitation (grade 2 or 3) was 13%, 4%, and 3%, respectively. Prevalences of grade 2 or 3 aortic regurgitation (8%, 4%, and 3%, respectively) and tricuspid regurgitation (4%, 6%, and 7%, respectively) were not significantly different among the three groups. Left ventricular hypertrophy (LVH) was found in 19% of subjects with PKD1, 6% of unaffected relatives, and 4% of control subjects. Systolic blood pressure and severity of renal insufficiency were related to mitral regurgitation and LVH in subjects with PKD1. The prevalence of cardiac valve abnormalities did not differ between unaffected relatives and control subjects. Mitral valve prolapse is a characteristic finding in patients with PKD1. Conversely, mitral regurgitation and LVH are likely to be secondary to elevated blood pressure in these patients.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
07:42An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
Related Concept Videos
Mitral Valve Prolapse I: Introduction
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management